#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15500	16S	1529	1529	100.0	16S.l15.c17.ctg.2	2360	785.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1449	1449	C	936	C,T	935,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25806	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4003	803.1	0	.	n	.	0	T695C	SNP	695	695	T	1305	1305	C	948	C,T	946,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25806	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4003	803.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1947	1947	A	1057	A,G,C	1054,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25806	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4003	803.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2581	2581	C	921	C,G,A	919,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25806	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4003	803.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2655	2655	A	859	A,T,G	857,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25806	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4003	803.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3207	3207	C	908	C,G,A,T	903,2,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2176	folP	855	855	100.0	folP.l15.c4.ctg.1	2150	126.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1400	1402	AGC	227;225;228	A;G;C	227;225;228	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4982	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3872	160.4	1	SNP	p	S91F	1	.	.	271	273	TTC	861	863	TTC	183;185;184	T;T;C	183;185;184	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4982	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3872	160.4	1	SNP	p	D95G	1	.	.	283	285	GGC	873	875	GGC	186;185;182	G;G;C	186;185;182	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4982	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3872	160.4	1	SNP	p	G95N	0	.	.	283	285	GGC	873	875	GGC	186;185;182	G;G;C	186;185;182	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1964	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1936	126.7	1	SNP	p	G45D	0	.	.	133	135	GGC	780	782	GGC	203;205;205	G;G;C,T	203;205;204,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1092	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1675	81.4	0	.	n	.	0	A197.	DEL	197	197	A	869	869	A	222	A	222	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4934	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3628	169.8	1	SNP	p	D86N	0	.	.	256	258	GAC	951	953	GAC	208;209;208	G;A,G,T;C	208;207,1,1;208	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4934	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3628	169.8	1	SNP	p	S87R	1	.	.	259	261	CGT	954	956	CGT	210;207;208	C;G;T	210;207;208	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4934	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3628	169.8	1	SNP	p	R87W	0	.	.	259	261	CGT	954	956	CGT	210;207;208	C;G;T	210;207;208	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4934	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3628	169.8	1	SNP	p	R87I	0	.	.	259	261	CGT	954	956	CGT	210;207;208	C;G;T	210;207;208	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4934	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3628	169.8	1	SNP	p	S88P	0	.	.	262	264	TCC	957	959	TCC	213;213;213	T;C;C	213;213;213	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4354	parE	1986	1986	100.0	parE.l6.c30.ctg.1	3332	163.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1923	1925	GGC	250;250;248	G;G;C	250;250;248	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1482	1484	GCA	229;231;229	G;C;A,G	229;231;228,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1485	1487	ATC	229;229;225	A;T;C,T	229;229;224,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1497	1499	GTG	226;227;227	G;T;G	226;227;227	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1497	1499	GTG	226;227;227	G;T;G	226;227;227	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2001	2003	ACC	218;220;222	A,C;C;C	217,1;220;222	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2055	2057	GCG	223;223;222	G;C,G;G	222;221,1;221	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2055	2057	GCG	223;223;222	G;C,G;G	222;221,1;221	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2178	2180	AGC	225;224;225	A;G;C,G	225;224;224,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2187	2189	GGC	225;225;219	G;G;C,A	225;225;218,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3944	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2959	166.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2205	2207	CCG	209;211;213	C,G;C;G,C	208,1;211;212,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5612	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3568	195.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1954	1956	CCG	257;258;257	C;C;G,A	257;258;255,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2496	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2321	134.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	829	829	C	185	C	185	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	240	porB1a	984	155	92.9	porB1a.l15.c17.ctg.5	155	37.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	22;22;22	T;T;A	22;22;22	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	240	porB1a	984	155	92.9	porB1a.l15.c17.ctg.5	155	37.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	47;47;47	C;A;T	47;47;47	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	240	porB1a	984	155	92.9	porB1a.l15.c17.ctg.5	155	37.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	47;47;47	A;G;T	47;47;47	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	240	porB1a	984	155	92.9	porB1a.l15.c17.ctg.5	155	37.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	47;47;47	T;A;C,A	47;47;46,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2948	porB1b	1035	1035	98.09	porB1b.l6.c30.ctg.1	1991	184.5	0	.	p	.	0	E41K	NONSYN	121	123	GAA	642	644	AAA	251;251;252	A,G;A;A	250,1;251;252	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2948	porB1b	1035	1035	98.09	porB1b.l6.c30.ctg.1	1991	184.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1152	1152	T	263	T	263	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2948	porB1b	1035	1035	98.09	porB1b.l6.c30.ctg.1	1991	184.5	1	SNP	p	G120K	0	.	.	358	360	GGT	879	881	GGT	243;242;242	G;G;T,G	243;242;241,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2948	porB1b	1035	1035	98.09	porB1b.l6.c30.ctg.1	1991	184.5	1	SNP	p	A121D	0	.	.	361	363	GCC	882	884	GCC	242;241;239	G,A;C;C,T	241,1;241;238,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2948	porB1b	1035	1035	98.09	porB1b.l6.c30.ctg.1	1991	184.5	1	SNP	p	A121N	0	.	.	361	363	GCC	882	884	GCC	242;241;239	G,A;C;C,T	241,1;241;238,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9928	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5349	231.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1400	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1501	115.9	1	SNP	p	V57M	1	.	.	169	171	ATG	721	723	ATG	262;262;260	A,C;T,G;G,C	261,1;261,1;259,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
